SANOFI INDIA
|
SANOFI INDIA Last 5 Year Financial Ratios History
[Standalone]
| Dec2023 | Dec2022 | Dec2021 | Dec2020 | Dec2019 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 262.26 | 269.83 | 410.61 | 207.65 | 180.09 |
| CEPS(Rs) | 279.48 | 288.04 | 439.61 | 243.39 | 223.52 |
| DPS(Rs) | 167.00 | 570.00 | 490.00 | 365.00 | 349.00 |
| Book NAV/Share(Rs) | 411.83 | 527.65 | 941.52 | 897.83 | 1,043.48 |
| Tax Rate(%) | 28.68 | 28.20 | 24.90 | 29.47 | 30.96 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 27.08 | 24.09 | 25.78 | 24.57 | 20.74 |
| EBIT Margin(%) | 28.59 | 29.68 | 42.60 | 23.40 | 18.71 |
| Pre Tax Margin(%) | 28.53 | 29.62 | 42.54 | 23.34 | 18.70 |
| PAT Margin (%) | 20.35 | 21.27 | 31.94 | 16.46 | 12.91 |
| Cash Profit Margin (%) | 21.69 | 22.70 | 34.20 | 19.29 | 16.03 |
| Performance Ratios | |||||
| ROA(%) | 12.66 | 11.95 | 17.74 | 9.24 | 8.28 |
| ROE(%) | 55.83 | 36.73 | 44.65 | 21.39 | 18.07 |
| ROCE(%) | 73.98 | 49.47 | 57.98 | 29.77 | 25.75 |
| Asset Turnover(x) | 0.62 | 0.56 | 0.56 | 0.56 | 0.64 |
| Sales/Fixed Asset(x) | 5.48 | 5.42 | 4.23 | 3.48 | 3.43 |
| Working Capital/Sales(x) | 4.98 | 3.36 | 2.13 | 2.53 | 2.25 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.18 | 0.18 | 0.24 | 0.29 | 0.29 |
| Receivable days | 16.06 | 17.01 | 17.96 | 23.40 | 21.76 |
| Inventory Days | 65.99 | 50.06 | 46.94 | 52.68 | 54.20 |
| Payable days | 98.45 | 112.47 | 97.06 | 100.04 | 96.53 |
| Valuation Parameters | |||||
| PER(x) | 30.76 | 21.68 | 19.22 | 40.06 | 38.96 |
| PCE(x) | 28.86 | 20.31 | 17.95 | 34.17 | 31.39 |
| Price/Book(x) | 19.59 | 11.09 | 8.38 | 9.26 | 6.72 |
| Yield(%) | 2.07 | 9.74 | 6.21 | 4.39 | 4.97 |
| EV/Net Sales(x) | 6.37 | 4.49 | 5.62 | 6.18 | 4.89 |
| EV/Core EBITDA(x) | 20.88 | 16.03 | 19.84 | 22.32 | 19.76 |
| EV/EBIT(x) | 21.42 | 14.36 | 13.18 | 26.40 | 25.00 |
| EV/CE(x) | 17.87 | 9.75 | 2.99 | 3.52 | 2.86 |
| M Cap / Sales | 6.51 | 4.86 | 6.14 | 6.59 | 5.25 |
| Growth Ratio | |||||
| Net Sales Growth(%) | 2.92 | -6.31 | 1.88 | -5.49 | 10.82 |
| Core EBITDA Growth(%) | 12.04 | -7.29 | 4.23 | 5.73 | 6.48 |
| EBIT Growth(%) | -2.14 | -31.24 | 85.48 | 13.13 | -1.69 |
| PAT Growth(%) | -2.80 | -34.29 | 97.74 | 15.31 | 8.83 |
| EPS Growth(%) | -2.80 | -34.29 | 97.74 | 15.31 | 8.83 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | - | - | - | - | - |
| Current Ratio(x) | 1.23 | 1.32 | 1.60 | 1.68 | 1.85 |
| Quick Ratio(x) | 0.97 | 1.17 | 1.43 | 1.46 | 1.57 |
| Interest Cover(x) | 498.53 | 509.41 | 699.67 | 377.22 | 2,000.67 |
| Total Debt/Mcap(x) | - | - | - | - | - |
Compare Financial Ratios of peers of SANOFI INDIA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SANOFI INDIA | ₹14,151.8 Cr | -1.2% | -1.4% | -23.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹451,603.0 Cr | 2.9% | 6.4% | 48.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹160,862.0 Cr | 0.5% | -2.1% | 59.2% | Stock Analytics | |
| CIPLA | ₹122,810.0 Cr | 2.3% | 1% | 20.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,946.0 Cr | 3.5% | 15.7% | 20.3% | Stock Analytics | |
| ZYDUS LIFESCIENCES | ₹96,377.1 Cr | -0.1% | 2.3% | 41.1% | Stock Analytics | |
SANOFI INDIA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SANOFI INDIA | -1.2% |
-1.4% |
-23.9% |
| SENSEX | 0.3% |
-2.5% |
10% |
You may also like the below Video Courses
